Jeffrey Bluestone, Sonoma CEO (Photo credit: Steve Babuljak)
Jeff Bluestone just raised $265M to develop curative cell therapies. We asked him how
Jeff Bluestone had some big goals in mind when he decided to make a switch from a decades-long career in academia and non-profit research …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
